Team Up to Manage IBS: Gastro Endo News Report

(MedPage Today) -- Also, deciding who gets liver transplant takes emotional toll
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news

Related Links:

Publication date: Available online 17 May 2019Source: Journal of Vascular and Interventional RadiologyAuthor(s): Tyler Sandow, John Pavlus, David Field, Eduardo Lacayo, Emil Cohen, George Lynskey, Theresa Caridi, Donna Buckley, John Cardella, Bhaskar Kallakury, James Spies, Alexander Y. KimAbstractPurposeTo evaluate tumor response to transarterial chemoembolization as well as biologic characteristics of the tumor as predictors of recurrence after transplantation in patients with hepatocellular carcinoma (HCC) who were bridged or down-staged to liver transplantation.Materials and MethodsAn institutional review board-approve...
Source: Journal of Vascular and Interventional Radiology - Category: Radiology Source Type: research
AbstractPurpose of ReviewWe aim to review the current guidelines and emerging data and compare the pros and cons for the use of HCV-positive organs.Recent FindingsSome recent data suggests that the use of HCV-positive livers and kidneys safely increases the organ pool, additionally reducing wait list time, healthcare costs, and mortality.SummaryDespite this therapeutic breakthrough, the demand for organs and waitlist mortality remains high. Every year, thousands of viable hepatitis C-positive organs are discarded. The emerging data regarding transplantation of HCV-positive organs is promising; however, further research is ...
Source: Current Hepatitis Reports - Category: Infectious Diseases Source Type: research
Abstract PURPOSE OF REVIEW: Owing to long waitlist times and high waitlist morbidity and mortality, strategies to increase utilization of hepatitis C viremic-deceased donor organs are under investigation in kidney, liver, heart, and lung transplantation. RECENT FINDINGS: Direct-acting antiviral medications for hepatitis C virus infection have high cure rates and are well tolerated. Small, single-center trials in kidney and heart transplant recipients have demonstrated that with early posttransplant direct-acting antiviral therapy, 100% of uninfected recipients of hepatitis C viremic organs have been cured of ...
Source: Current Opinion in Organ Transplantation - Category: Transplant Surgery Authors: Tags: Curr Opin Organ Transplant Source Type: research
Abstract PURPOSE OF REVIEW: Scarcity is a defining feature of the modern transplant landscape, and in light of chronic shortages in donor organs, there is cause for concern about geographic inequities in patients' access to lifesaving resources. Recent policy changes designed to ameliorate unequal donor supply and demand have brought new interest to measuring and addressing disparities at all stages of transplant care. The purpose of this review is to describe an overview of recent literature on geographic inequities in transplant access, focusing on kidney, liver, and lung transplantation and the impact of policy...
Source: Current Opinion in Organ Transplantation - Category: Transplant Surgery Authors: Tags: Curr Opin Organ Transplant Source Type: research
Authors: Boyd A, Newsome P, Lu WY Abstract INTRODUCTION: Liver disease is an increasing cause of worldwide mortality, and currently the only curative treatment for end-stage liver disease is whole organ allograft transplantation. Whilst this is an effective treatment, there is a shortage of suitable grafts and consequently some patients die whilst on the waiting list. Cell therapy provides an alternative treatment to increase liver function and potentially ameliorate fibrosis. Areas covered: In this review we discuss the different cellular sources for therapy investigated to date in humans include mature hepatocyte...
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
Patients, doctors in less populated parts of the country seek contempt order against HHS and the nonprofit that runs the transplant system.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
This article is protected by copyright. All rights reserved.
Source: Journal of Hepato-Biliary-Pancreatic Sciences - Category: Gastroenterology Authors: Tags: Review Article Source Type: research
To evaluate tumor response to transarterial chemoembolization as well as biologic characteristics of the tumor as predictors of recurrence after transplantation in patients with hepatocellular carcinoma (HCC) who were bridged or down-staged to liver transplantation.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Clinical Study Source Type: research
Hepatocellular carcinoma (HCC) is the most common primary hepatic malignancy and the third most frequent cause of cancer-related deaths.[1,2] Although the prognosis of patients with advanced HCC remains poor, patients with early-stage HCC are eligible for curative treatments such as surgical resection, local ablation, and liver transplantation.[3,4] Therefore, accurate imaging diagnosis of early-stage HCC is important.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
Donors with low-body-weight were previously reported to be related to inferior recipient outcomes in pediatric liver transplantation. However, the scarce availability of age and size-matched organs has encouraged us to re-evaluate the feasibility and safety of using low-body-weight donors.
Source: Journal of Pediatric Surgery - Category: Surgery Authors: Source Type: research
More News: Gastroenterology | Liver | Liver Transplant | Primary Care | Transplant Surgery | Transplants | Urology & Nephrology